Salute e Benessere
Tethis and Sheba Medical Center announce research collaboration to advance AI-powered liquid biopsy in rectal cancer
states Dr. Holger Neecke , CEO of Tethis.
says Prof. Iris Barshack , Head of the Pathology Institute.
, says Dr. Nadia Prisant , Head of the Liquid Biopsy Laboratory.
adds Prof. Ruth Katz , Professor of Pathology.
The See.d instrument and SmartBioSurface slides are for Research Use Only and are not intended for use in diagnostic procedures.
Tethis is a diagnostic company developing an innovative workflow to integrate liquid biopsy into clinical practice, offering precise cancer management. Tethis' technology focuses on standardizing the preparation of blood samples to ensure the highest quality and integrity of liquid biopsy specimens. This approach facilitates comprehensive analysis of all clinically relevant biomarkers. The company's nanocoated SmartBioSurface slides, in conjunction with the See.d instrument, enable the identification and characterization of immune cells and rare cells, such as circulating tumor cells, with unparalleled sensitivity, even in early-stage settings. The company is headquartered in Milan, Italy . More information can be found at www.tethis-lab.com.
The largest and most comprehensive medical center in the Middle East , Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research and AI-based healthcare transformation. Sheba's City of Health boasts acute-care, rehabilitation, children's, cancer and geriatric hospitals, research and innovation hubs, medical simulation center, center for disaster response and a virtual hospital on one comprehensive campus in the center of Israel . Sheba serves as a true hospital without borders, welcoming patients and healthcare professionals from all over the world and consistently providing the highest-level medical care to all in need. For more information, visit: https://sheba-global.com.
For Tethis
media@tethis-lab.com
View original content:https://www.prnewswire.co.uk/news-releases/tethis-and-sheba-medical-center-announce-research-collaboration-to-advance-ai-powered-liquid-biopsy-in-rectal-cancer-302396406.html